Clinical Trial Update: A Study of DS-1471a In Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

DS-1471a was evaluated in a Phase 1 study for advanced solid tumors, and the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DS-1471a

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED